This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: California Institute of Technology, University of California. Active years: 2022-2023.
Company Filing History:
2 out of 4,624 
2 out of 15,988 
Years Active: 2022-2023
Title: Brittany D Needham: Innovator in Microbial Synthesis
Introduction
Brittany D Needham is a prominent inventor based in Pasadena, CA (US). She has made significant contributions to the field of microbial synthesis, particularly in relation to mental health disorders. With a total of 2 patents, her work focuses on the modulation of bacterial metabolites that can impact behavior and disease.
Latest Patents
Her latest patents include innovative methods for the modulation of microbial synthesis of 4-ethylphenol and 4-ethylphenyl sulfate. These patents describe genetically engineered bacterial strains designed to regulate the levels of these metabolites in the gut. The bacteria can potentially reduce or inhibit the production of 4-ethylphenol (4EP) or its sulfated form, 4-ethylphenyl sulfate (4EPS). This modulation may help ameliorate, delay the onset, or reduce the likelihood of symptoms associated with anxiety and autism spectrum disorder (ASD) in subjects.
Career Highlights
Brittany has worked with esteemed institutions such as the California Institute of Technology and the University of California. Her research has garnered attention for its potential applications in improving mental health through microbial interventions.
Collaborations
Brittany has collaborated with notable researchers, including Sarkis K Mazmanian and Gil Sharon. These partnerships have contributed to her innovative research and the development of her patents.
Conclusion
Brittany D Needham is a trailblazer in the field of microbial synthesis, with her patents paving the way for new approaches to mental health treatment. Her work exemplifies the intersection of innovation and science, highlighting the potential of genetically engineered bacteria in addressing complex health issues.